Creative Planning’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2
| Closed | -$86 | – | 3719 |
|
|
2024
Q4 | $86 | Buy |
+2
| New | +$86 | ﹤0.01% | 3551 |
|
|
2022
Q2 | – | Sell |
-201
| Closed | -$9K | – | 2442 |
|
|
2022
Q1 | $9K | Buy |
+201
| New | +$9K | ﹤0.01% | 2170 |
|
|
2018
Q1 | – | Sell |
-11,488
| Closed | -$500K | – | 1988 |
|
|
2017
Q4 | $500K | Buy |
+11,488
| New | +$500K | ﹤0.01% | 1058 |
|
|
2017
Q3 | – | Sell |
-4,501
| Closed | -$194K | – | 3637 |
|
|
2017
Q2 | $194K | Buy |
4,501
+3,000
| +200% | +$129K | ﹤0.01% | 1522 |
|
|
2017
Q1 | $63K | Sell |
1,501
-4,987
| -77% | -$209K | ﹤0.01% | 2290 |
|
|
2016
Q4 | $254K | Buy |
6,488
+2,856
| +79% | +$112K | ﹤0.01% | 1272 |
|
|
2016
Q3 | $161K | Sell |
3,632
-3,274
| -47% | -$145K | ﹤0.01% | 1527 |
|
|
2016
Q2 | $289K | Sell |
6,906
-9,166
| -57% | -$384K | ﹤0.01% | 1073 |
|
|
2016
Q1 | $647K | Buy |
16,072
+11,324
| +239% | +$456K | 0.01% | 660 |
|
|
2015
Q4 | $243K | Sell |
4,748
-7,648
| -62% | -$391K | ﹤0.01% | 1085 |
|
|
2015
Q3 | $582K | Buy |
+12,396
| New | +$582K | 0.01% | 678 |
|
|
2015
Q2 | – | Sell |
-5,116
| Closed | -$316K | – | 2919 |
|
|
2015
Q1 | $316K | Buy |
5,116
+2,112
| +70% | +$130K | ﹤0.01% | 962 |
|
|
2014
Q4 | $162K | Sell |
3,004
-1,100
| -27% | -$59.3K | ﹤0.01% | 1263 |
|
|
2014
Q3 | $218K | Buy |
4,104
+2,020
| +97% | +$107K | ﹤0.01% | 1012 |
|
|
2014
Q2 | $108K | Buy |
2,084
+522
| +33% | +$27.1K | ﹤0.01% | 1377 |
|
|
2014
Q1 | $73K | Buy |
1,562
+1,112
| +247% | +$52K | ﹤0.01% | 1579 |
|
|
2013
Q4 | $20K | Sell |
450
-828
| -65% | -$36.8K | ﹤0.01% | 2196 |
|
|
2013
Q3 | $49K | Buy |
1,278
+828
| +184% | +$31.7K | ﹤0.01% | 1521 |
|
|
2013
Q2 | $16K | Buy |
+450
| New | +$16K | ﹤0.01% | 2062 |
|